Biotech
CAMBRIDGE, MA: Promotes Ben Munoz, Ph.D. to Senior Vice President, Drug Discovery and Po-Shun Lee, M.D. to Executive Vice President and Chief Medical Officer ...
SYDNEY, AUSTRALIA: New Material Transfer Agreement (MTA) Concluded With Yamaguchi University and NEC Corporation Parties Have Combined a Cancer Vaccine With Prima's IMP321 Antigen Presenting Cell (APC) Activator Pr ...
DUBLIN, IRELAND: First-in-Human Study for Potentially Best-in-Class Treatment for Range of Inflammatory Intestinal Diseases ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 12/09/15 -- (NASDAQ: TTNP) and partner Braeburn Pharmaceuticals today announced that the U.S. Food and Drug Administration has scheduled a meeting of the ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 12/09/15 -- bioMmune Technologies Inc. ("bioMmune" or the "Company") (TSX VENTURE: IMU), a company focused on harnessing the body& ...
EDMONTON, ALBERTA: EDMONTON, ALBERTA -- (Marketwired) -- 12/08/15 -- BioNeutra Global Corporation ("BioNeutra" or the "Company") is pleased to announce that the common shares of the Company will be ...
DUBLIN, IRELAND: First Clinical Study for Compound From Company's Potential Best-in-Class NEP Inhibitor Development Program; Compound Designed for Broad Use in Major Cardiovascular and Renal Diseases ...
WINNIPEG, MANITOBA: WINNIPEG, MANITOBA -- (Marketwired) -- 12/08/15 -- Miraculins Inc. (TSX VENTURE: MOM) (the "Company"), a medical diagnostic company focused on acquiring, developing and commercializing dia ...
ATLANTA, GEORGIA: New Whole Blood Applications Powered by Medmira Rapid Vertical Flow Technology Revealed at Booth 109 ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 12/07/15 -- Revive Therapeutics Ltd. ("Revive" or the "Company") (TSX VENTURE: RVV)(OTCQB: RVVTF), a company focused on commercializing treat ...
SOUTH SAN FRANCISCO, CA: Studies of Evofosfamide Combined With Chemotherapy in Advanced Pancreatic Cancer (MAESTRO) and Advanced Soft Tissue Sarcoma (TH-CR-406/SARC021) Did Not Meet Primary Endpoints of Improving Overall Surv ...
BERKELEY, CA: First Clinical Data Presentation of SD-101 Demonstrates Encouraging Systemic Antitumor Activity ...
EDMONTON, ALBERTA: EDMONTON, ALBERTA -- (Marketwired) -- 12/03/15 -- (TSX VENTURE: CZO) ("Ceapro" or the "Company"), a growth-stage biotechnology company focused on the development and commercializ ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 12/03/15 -- Trillium Therapeutics Inc. (NASDAQ: TRIL)(TSX: TR) an immuno-oncology company developing innovative therapies for the treatment of cancer, today anno ...
DUBLIN, IRELAND: DUBLIN, IRELAND -- (Marketwired) -- 12/02/15 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") announced today that stock options to purchase ...
CLEVELAND, OH: Innovative Thermal Regulation Technology Aims to Raise and Lower Core Body Temperature Faster and Safer With Better Patient Outcomes ...
HALIFAX, NOVA SCOTIA: Early results in Phase 2 study show correlation between immune response and tumor changes: an important marker of a vaccine effect ...
GENEVA, SWITZERLAND: Late-Breaking Abstract on NI-0501 for Treatment of Hemophagocytic Lymphohistiocytosis (HLH) One of Only Eight Accepted ...
